Clinical and molecular aspects of juvenile hemochromatosis in Saguenay-Lac-Saint-Jean (Quebec, canada)

Blood Cells Mol Dis. 2000 Feb;26(1):10-4. doi: 10.1006/bcmd.2000.0271.

Abstract

We report the clinical, biochemical, and genetic characteristics of 13 hemochromatosis patients from Saguenay-Lac-Saint-Jean in whom the first symptoms appeared before age 30. Although the mean age at onset of the first symptoms was 21. 5 years, their mean age at diagnosis was 23.8 years; the diagnosis was particularly delayed among women. Seventy-seven percent of the patients had hypogonadotrophic hypogonadism and 69% heart failure and/or cardiac arrhythmias. Genetic analysis of the HFE gene revealed heterozygosity for the C282Y mutation in 2 patients and for the S65C mutation in 2 others and homozygosity for the H63D mutation in 1 patient. The remaining 8 patients had no identified mutation in the HFE gene, although sequencing of all seven codons and intron-exon junctions was performed (5 patients). All 13 patients fulfill the clinical criteria of juvenile hemochromatosis and represent the largest cluster thus far reported.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age of Onset
  • Child
  • DNA Mutational Analysis
  • Diabetes Mellitus / etiology
  • Family Health
  • Female
  • Ferritins / blood
  • Genotype
  • Heart Diseases / etiology
  • Hemochromatosis / blood
  • Hemochromatosis / complications
  • Hemochromatosis / genetics*
  • Humans
  • Hypogonadism / etiology
  • Iron / blood
  • Iron Overload / blood
  • Iron Overload / genetics
  • Liver Cirrhosis / etiology
  • Male
  • Mutation
  • Quebec
  • Transferrin / metabolism

Substances

  • Transferrin
  • Ferritins
  • Iron